Related Experiment Video
Updated: Nov 7, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Pediatric Glutaric Aciduria Type 1: 14 Cases, Diagnosis and Management
Leema P Cornelius1, Vivekasaravanan Raju1, Asir Julin1
1Department of Paediatric Neurology, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai, Tamil Nadu, India.
Early identification and management of Glutaric aciduria type I (GA-I), a lysine metabolism disorder, are crucial for better outcomes in affected children. This study highlights key clinical features and diagnostic delays in South Indian GA-I patients.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Glutaric aciduria type I (GA-I) is an inherited metabolic disorder affecting lysine breakdown, caused by a deficiency in glutaryl-CoA dehydrogenase.
- It typically presents with developmental regression and dystonia after infections.
- This study focuses on 14 South Indian children diagnosed with GA-I.
Purpose of the Study:
- To describe the clinical manifestations, diagnostic process, and management strategies for Glutaric aciduria type I in a South Indian cohort.
- To emphasize the importance of early diagnosis and intervention for improved patient outcomes.
Main Methods:
- Retrospective analysis of clinical data from 14 children diagnosed with Glutaric aciduria type I.
- Review of presenting symptoms, age at onset and diagnosis, family history, neurological findings, and neuroimaging results.
Main Results:
- Males constituted 57.1% of the cohort, with symptom onset around 8.57 months and diagnosis at a mean of 35.21 months.
- Consanguinity was present in 57.1% of families; 71.4% experienced developmental regression post-infection.
- Macrocephaly and characteristic 'bat's wing' appearance on imaging were common, with ~80% exhibiting moderate to severe neurological disability.
Conclusions:
- Glutaric aciduria type I requires prompt identification and intervention to improve prognosis.
- Delayed diagnosis impacts long-term neurological outcomes, underscoring the need for increased awareness and early screening.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Diabetes Mellitus: Type 2 and Gestational
Lysosomal Hydrolases
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...